Investigative Clinical Research of Indiana, LLC

18051 River Road
Suite 107
Noblesville, IN 46062
ph: 317-297-2208
fax: 317-297-1136
admin@investigativeicr.com

Clinical Trials - Hematology Oncology

The following is a comprehensive lists of our currently enrolling and ongoing trials.

Primary or secondary MF, ET, PV, or CMML
A Phase 1 Open-Label Study Evaluating the Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination with Ruxolitinib in Myeloproliferative Neoplasm Subjects
Multiple Myeloma
An Open-Label, Single-Arm, Multicenter Study to Evaluate the Effectiveness and Safety of Ixazomib (NINLARO) in Combination with Lenalidomide and Dexamethasone (IRD) in Patients with Multiple Myeloma Previously Receiving a Bortezomib-Based Triplet Induction Regimen
Follicular Lymphoma and Marginal Zone Lymphoma
A Multicenter, Open-Label, Single-Arm, Phase 2 Study of Zandelisib(ME-401) in subjects with Follicular Lymphoma or Marginal ZoneLymphoma After Failure of Two or More Prior Systemic Therapies
Paroxysmal Nocturnal Hemoglobinuria
OBSERVATIONAL REGISTRY STUDY OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN
Chronic Lymphocytic Leukemia
A Disease Registry for Patients with Chronic Lymphocytic Leukemia
Myelofibrosis and Essential Thrombocythemia
Prospective, Longitudinal, Non-Interventional Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocythemia (ET) or ET Patients Receiving ET-Directed Therapy
R/R Diffuse Large B-cell lymphoma
A PHASE 2/3, MULTICENTER RANDOMIZED STUDY OF RITUXIMAB-GEMCITABINE-DEXAMETHASONE-PLATINUM (R-GDP) WITH OR WITHOUT SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

18051 River Road
Suite 107
Noblesville, IN 46062
ph: 317-297-2208
fax: 317-297-1136
admin@investigativeicr.com